Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Bone Biologics Corp. (BBLG)

Avenue Therapeutics, Inc. and Bone Biologics Corp. are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $680.0K — 1.6× the size. Across the 8 metrics below, Avenue Therapeutics, Inc. leads on 4 and Bone Biologics Corp. on 4.

Valuation

Metric ATXI BBLG Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.49 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (197.67%) (438.22%) (32.88%)
Free cash flow yield (97.68%) (214.89%) (23.13%)

Profitability

Metric ATXI BBLG Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) (47.49%) (51.96%)
Return on assets (90.50%) (44.46%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI BBLG Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.11% 90.85% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI BBLG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 13.38 4.97
Net debt to EBITDA 0.93 1.65 1.01

Dividend

Metric ATXI BBLG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI BBLG Biotechnology median
Market cap 680.00k 1.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack